Today Rancho BioSciences, the premier tech-enabled data science partner for biopharma, announced the launch of OmicsHQTM, a unified catalog of expertly curated, standardized multi-omics datasets designed for immediate use in research, drug discovery, and AI/ML model development. The company is launching the product at BioIT World Conference & Expo, May 19, 2026, Boston, MA.
"OmicsHQ represents our commitment to removing the barriers that slow scientific progress," said Chris O'Brien, CEO of Rancho Biosciences. "By unifying fragmented data sources into a single, curated catalog with consistent standards, we are enabling researchers to move from search to analysis in a fraction of the time. This is multi-omics data excellence at scale, and it is available at scientists' fingertips starting today."
Analysis-and AI-Ready Data, From Day One
Today, multi-omics data is scattered across dozens of repositories, inconsistently annotated, and rarely ready for downstream analysis without significant manual effort. OmicsHQTM changes that.
At launch, OmicsHQTM provides researchers with a single, searchable catalog of single-cell transcriptomics data, including over 1,000 preprocessed datasets ready for immediate use, and more than 8,000 additional studies available for on-demand processing. All datasets undergo a rigorous multi-step curation workflow. Every dataset is prescreened for completeness, harmonized against standard ontologies (UBERON, DOID, EFO, MESH, NCIT), processed through a reproducible bioinformatics pipeline, and independently quality-reviewed. Datasets are available for download in H5AD and Seurat formats, with no additional preprocessing or harmonization required. Additional data modalities will continue to be added over time.
Researchers can visualize UMAP and PCA embeddings, explore gene expression, and evaluate quality control metrics directly within the platform before downloading, making it easier to identify the right dataset before committing time and compute resources.
Built for Drug Development
OmicsHQTM is designed to support the workflows scientists rely on most, including AI and machine learning model development, target and biomarker discovery, and disease-focused data sourcing. Standardized metadata and consistent data structures allow teams to integrate datasets directly into existing pipelines, run cross-study analyses, and validate findings without the friction of manual curation.
For organizations building foundation models or training AI on biological data, OmicsHQTM provides a reliable, scalable source of harmonized multi-omics data that is ready to use from the moment of download. There is no ongoing platform dependency; datasets are purchased once and owned indefinitely.